Genomic characterization and molecular predictive biomarkers for chemotherapy in a real-world population with metastatic triple-negative breast cancer

被引：0
|
作者：
Olsson, Erik
Lindman, Henrik
Digkas, Evangelos
Thurfjell, Viktoria
Ali, Haidar Mir
Kruger, Ute
Wennstig, Anna-Karin
Sundqvist, Marie
Valachis, Antonis
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO4-15-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO4-15-05
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Characteristics, behaviour and role of biomarkers in metastatic triple-negative breast cancer
    Goto, Yutaro
    Thike, Aye Aye
    Ong, Clara Chong Hui
    Lim, Johnathan Xiande
    Nasir, Nur Diyana Md
    Li, Huihua
    Koh, Valerie Cui Yun
    Chen, Xiao-Yang
    Yeong, Joe Poh Sheng
    Sasano, Hironobu
    Tan, Puay Hoon
    JOURNAL OF CLINICAL PATHOLOGY, 2020, 73 (03) : 147 - 153
  • [22] Correction: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer
    Weiwei Huang
    Chenxi Wang
    Yangkun Shen
    Qi Chen
    Zhijian Huang
    Jian Liu
    Xiaoyan Lin
    Lili Wang
    Fan Wu
    Xinhua Chen
    Nani Li
    Yi Hong
    Mulan Chen
    Jieyu Li
    Chuanzhong Huang
    BMC Cancer, 24
  • [23] Assessing Real-World Racial Differences Among Patients With Metastatic Triple-Negative Breast Cancer in US Community Practices
    Tan, Ruoding
    Cassoli, Lourenia
    Yan, Ying
    Shen, Vincent
    Day, Bann-mo
    Mitchell, Edith P.
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [24] Utilization and outcomes of eribulin in triple negative metastatic breast cancer: Real-world findings
    Kish, J. K.
    Mougalian, S. S.
    Copher, R.
    McAllister, L.
    Zhixiao, W.
    Broscious, M.
    CANCER RESEARCH, 2017, 77
  • [25] Real-world effectiveness outcomes by race in patients with metastatic triple negative breast cancer
    Skinner, K. E.
    Dufour, R.
    Haiderali, A.
    Huang, M.
    Schwartzberg, L. S.
    CANCER RESEARCH, 2019, 79 (04)
  • [26] Real-world efficacy and safety of neoadjuvant pembrolizumab plus chemotherapy in Brazilian patients with earlystage triple-negative breast cancer
    Sousa, Isadora
    Comini, Ana Carolina M.
    Borges, Italo
    Balint, Flavia C.
    Martins, Livia Alexandre
    Sousa, Debora G.
    Sanches, Solange M.
    Cesca, Marcelle G.
    Cordeiro de Lima, Vladmir
    Tavares, Monique
    CANCER RESEARCH, 2024, 84 (09)
  • [27] Genomic Characteristics of Triple-Negative Breast Cancer Nominate Molecular Subtypes That Predict Chemotherapy Response
    Kim, Jihyun
    Yu, Doyeong
    Kwon, Youngmee
    Lee, Keun Seok
    Sim, Sung Hoon
    Kong, Sun-Young
    Lee, Eun Sook
    Park, In Hae
    Park, Charny
    MOLECULAR CANCER RESEARCH, 2020, 18 (02) : 253 - 263
  • [28] Dose-dense neoadjuvant chemotherapy in triple-negative breast cancer: Real-world data from a developing country
    Sharma, Rakesh Kumar
    Gogia, Ajay
    Deo, S. V. S.
    Sharma, Dayanand
    Mathur, Sandeep
    Sagiraju, Hari Krishna Raju
    INDIAN JOURNAL OF CANCER, 2023, 60 (04) : 505 - 511
  • [29] Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer.
    O'Shaughnessy, Joyce
    Osborne, Cynthia
    Pippen, John E.
    Yoffe, Mark
    Patt, Debra
    Rocha, Christine
    Koo, Ingrid Chou
    Sherman, Barry M.
    Bradley, Charles
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (03): : 205 - 214
  • [30] Atorvastatin facilitates chemotherapy effects in metastatic triple-negative breast cancer
    Marti, Juan Luis Gomez
    Beckwitt, Colin H.
    Clark, Amanda M.
    Wells, Alan
    BRITISH JOURNAL OF CANCER, 2021, 125 (09) : 1285 - 1298
12345